Brain Tumor Panel

Brain Tumor Panel

BRAIN TUMOR PANEL

IDH1 Mutation

Glioblastoma, the aggressive brain tumor is characterized by the wild-type Arginine residue at amino acid position 132. Tumors with any mutation changing the R132 to H, C, or S have been strongly associated with a better prognosis. Thus, WHO has recommended the test as the first test for classifying brain tumors.

Technique: ddPCR

TAT: 24 Hours

1P19Q Double Deletion

The tumor is classified as Oligodendroglioma if it has a mutated amino acid at position 132 and harbors the double deletion of 1p and 19q

Technique: FISH

TAT: 48 Hours TAT: 48 Hours

Address

Mazumdar Shaw Medical Foundation A-Block, 8th Floor #258/A, NH Health City Bangalore - 560 099

Integrated Head and Neck Oncology Program

Stem Cell Program

Molecular Immunology

Neuro-oncology Program

Gynaec-oncology Program

Product Research

Computational Biology

Advanced Diagnostic Research Center

Cancer Outreach Program

Technology Business Incubator

Our Test

Hospital Profile

Book This Services